Clinical Outcomes of Extended Versus Intermittent Infusion of Piperacillin/Tazobactam in Critically Ill Patients: A Prospective Clinical Trial

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy Pub Date : 2017-01-01 DOI:10.1002/phar.1875

Sheung-Yin Fan, H. Shum, W. Cheng, Yat-Hei Chan, Sik-Yin McShirley Leung, W. Yan

引用次数: 23

Abstract

To determine whether critically ill patients receiving extended‐infusion (EI) piperacillin/tazobactam would have improved clinical outcomes compared with patients receiving intermittent infusions.

查看原文本刊更多论文

延长输注哌拉西林/他唑巴坦与间歇输注哌拉西林/他唑巴坦对危重患者的临床效果:一项前瞻性临床试验

确定接受延长输注(EI)哌拉西林/他唑巴坦的危重患者与接受间歇输注的患者相比是否能改善临床结果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

自引率

0.00%

发文量